Asher Kornbluth

Summary

Affiliation: Mount Sinai School of Medicine
Country: USA

Publications

  1. ncbi Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee
    Asher Kornbluth
    Samuel Bronfman Department of Medicine, Mount Sinai School of Medicine, New York, NY, USA
    Am J Gastroenterol 105:501-23; quiz 524. 2010
  2. ncbi Cyclosporine and infliximab as rescue therapy for each other in patients with steroid-refractory ulcerative colitis
    Elana A Maser
    The IBD Center, Division of Gastroenterology, Mount Sinai Medical Center, New York, New York 10029, USA
    Clin Gastroenterol Hepatol 6:1112-6. 2008
  3. ncbi Optimizing drug therapy in inflammatory bowel disease
    Arun Swaminath
    Henry D Janowitz Division of Gastroenterology, Mount Sinai School of Medicine, 1425 Madison Avenue, Box 1069, New York, NY 10029, USA
    Curr Gastroenterol Rep 9:513-20. 2007
  4. ncbi Adverse events associated with the use of cyclosporine in patients with inflammatory bowel disease
    Michael B Sternthal
    The Dr Henry D Janowitz Division of Gastroenterology, Department of Medicine, Mount Sinai Medical Center, New York, New York 10028, USA
    Am J Gastroenterol 103:937-43. 2008
  5. ncbi Progression to colorectal neoplasia in ulcerative colitis: effect of mesalamine
    Thomas Ullman
    Dr Henry D Janowitz Division of Gastroenterology, Department of Medicine, Mount Sinai School of Medicine, New York, New York 10029, USA
    Clin Gastroenterol Hepatol 6:1225-30; quiz 1177. 2008
  6. ncbi Video capsule endoscopy in inflammatory bowel disease: past, present, and future redux
    Arun Swaminath
    Department of Medicine, Division of Gastroenterology and Hepatology, Columbia University Medical Center, New York, New York 10032, USA
    Inflamm Bowel Dis 16:1254-62. 2010
  7. ncbi Video capsule endoscopy in inflammatory bowel disease 2005
    Peter Legnani
    The Henry D. Janowitz Division of Gastroenterology, The Mount Sinai Medical Center, New York, New York 10128, USA
    Curr Opin Gastroenterol 21:438-42. 2005
  8. ncbi Mucosal dysplasia in ileal pelvic pouches after restorative proctocolectomy
    Naris Nilubol
    Department of Surgery, The Mount Sinai Hospital, New York, New York, USA
    Dis Colon Rectum 50:825-31. 2007
  9. ncbi Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee
    Asher Kornbluth
    The Henry D. Janowitz Division of Gastroenterology, The Department of Medicine, Mount Sinai School of Medicine, The Mount Sinai Medical Center, New York, NY 10128, USA
    Am J Gastroenterol 99:1371-85. 2004
  10. ncbi Do guidelines matter? Implementation of the ACG and AGA osteoporosis screening guidelines in inflammatory bowel disease (IBD) patients who meet the guidelines' criteria
    Asher Kornbluth
    The Henry D Janowitz Division of Gastroenterology, The Mount Sinai Medical Center, New York, New York, USA
    Am J Gastroenterol 101:1546-50. 2006

Detail Information

Publications13

  1. ncbi Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee
    Asher Kornbluth
    Samuel Bronfman Department of Medicine, Mount Sinai School of Medicine, New York, NY, USA
    Am J Gastroenterol 105:501-23; quiz 524. 2010
    ..Grade C recommendations are based on level 4 studies, meaning case series or poor-quality cohort studies, and grade D recommendations are based on level 5 evidence, meaning expert opinion...
  2. ncbi Cyclosporine and infliximab as rescue therapy for each other in patients with steroid-refractory ulcerative colitis
    Elana A Maser
    The IBD Center, Division of Gastroenterology, Mount Sinai Medical Center, New York, New York 10029, USA
    Clin Gastroenterol Hepatol 6:1112-6. 2008
    ..If the patient then fails either of these drugs, it is unknown whether success can be achieved by using the other agent. The aim of this study was to assess outcomes of using cyclosporine after failure of infliximab, and vice versa...
  3. ncbi Optimizing drug therapy in inflammatory bowel disease
    Arun Swaminath
    Henry D Janowitz Division of Gastroenterology, Mount Sinai School of Medicine, 1425 Madison Avenue, Box 1069, New York, NY 10029, USA
    Curr Gastroenterol Rep 9:513-20. 2007
    ..Lastly, additional information regarding the optimal method for using anti-tumor necrosis factor therapy continues to accumulate...
  4. ncbi Adverse events associated with the use of cyclosporine in patients with inflammatory bowel disease
    Michael B Sternthal
    The Dr Henry D Janowitz Division of Gastroenterology, Department of Medicine, Mount Sinai Medical Center, New York, New York 10028, USA
    Am J Gastroenterol 103:937-43. 2008
    ..Intravenous cyclosporine (i.v. CsA) is an effective therapy for patients with inflammatory bowel disease (IBD). However, data regarding its adverse events in these patients are limited...
  5. ncbi Progression to colorectal neoplasia in ulcerative colitis: effect of mesalamine
    Thomas Ullman
    Dr Henry D Janowitz Division of Gastroenterology, Department of Medicine, Mount Sinai School of Medicine, New York, New York 10029, USA
    Clin Gastroenterol Hepatol 6:1225-30; quiz 1177. 2008
    ..The aim of this study was to compare rates of progression with advanced neoplasia in patient cohorts with UC taking low and high doses of mesalamine and to determine where in the process of neoplastic progression mesalamine might act...
  6. ncbi Video capsule endoscopy in inflammatory bowel disease: past, present, and future redux
    Arun Swaminath
    Department of Medicine, Division of Gastroenterology and Hepatology, Columbia University Medical Center, New York, New York 10032, USA
    Inflamm Bowel Dis 16:1254-62. 2010
    ....
  7. ncbi Video capsule endoscopy in inflammatory bowel disease 2005
    Peter Legnani
    The Henry D. Janowitz Division of Gastroenterology, The Mount Sinai Medical Center, New York, New York 10128, USA
    Curr Opin Gastroenterol 21:438-42. 2005
    ..Prospective comparative studies with adequate control groups and predefined clinical endpoints are necessary to determine the true role of this technology in Crohn's disease...
  8. ncbi Mucosal dysplasia in ileal pelvic pouches after restorative proctocolectomy
    Naris Nilubol
    Department of Surgery, The Mount Sinai Hospital, New York, New York, USA
    Dis Colon Rectum 50:825-31. 2007
    ..This study was designed to determine the prevalence of mucosal dysplasia in ileal pouch and any associated risk factors...
  9. ncbi Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee
    Asher Kornbluth
    The Henry D. Janowitz Division of Gastroenterology, The Department of Medicine, Mount Sinai School of Medicine, The Mount Sinai Medical Center, New York, NY 10128, USA
    Am J Gastroenterol 99:1371-85. 2004
    ..New developments in medical research and practice pertinent to each guideline will be reviewed at a time established and indicated at the publication in order to assure continued validity...
  10. ncbi Do guidelines matter? Implementation of the ACG and AGA osteoporosis screening guidelines in inflammatory bowel disease (IBD) patients who meet the guidelines' criteria
    Asher Kornbluth
    The Henry D Janowitz Division of Gastroenterology, The Mount Sinai Medical Center, New York, New York, USA
    Am J Gastroenterol 101:1546-50. 2006
    ..The objective of this study was to determine the yield of implementing the Guidelines' recommendations in a prospective cohort of IBD patients and identify the prevalence of bone loss, risk factors, and potential influence on management...
  11. ncbi Are your patients taking their medicine? Validation of a new adherence scale in patients with inflammatory bowel disease and comparison with physician perception of adherence
    Arvind J Trindade
    Dr Henry D Janowitz Division of Gastroenterology, Department of Medicine, Mount Sinai School of Medicine, New York, New York 10029, USA
    Inflamm Bowel Dis 17:599-604. 2011
    ..The aim was to administer an improved medication adherence survey to IBD patients, to validate the scale in IBD, and to compare the results to perceived adherence by the gastroenterologists...
  12. ncbi Serologic and genetic markers do not aid in the determination of the clinical course and severity of patients with inflammatory bowel disease
    Seamus J Murphy
    Dr Henry D Janowitz Division of Gastroenterology, Mount Sinai Medical Center, New York, New York, USA
    Inflamm Bowel Dis 14:129-31; discussion 132-3. 2008
  13. ncbi Video capsule endoscopy in inflammatory bowel disease: past, present, and future
    Asher Kornbluth
    Henry D Janowitz Division of Gastroenterology, The Mount Sinai Medical Center, New York, New York, USA
    Inflamm Bowel Dis 10:278-85. 2004
    ..We will review the currently limited data on its use in IBD and discuss future areas of investigation required to evaluate critically its potential utility in these patients...